Literature DB >> 32299770

Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor.

Lucie Robert1, Sophie Langner-Lemercier2, Alexis Angibaud3, Alexandre Sale3, Fanny Thepault4, Romain Corre5, Hervé Lena5, Charles Ricordel6.   

Abstract

Entities:  

Keywords:  Atezolizumab; Immune encephalitis; Immune-related adverse events; NSCLC; Nivolumab

Year:  2020        PMID： 32299770     DOI： 10.1016/j.cllc.2020.03.006

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  4 in total

Review 1.  Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.

Authors:  Kirit Singh; Kelly M Hotchkiss; Kisha K Patel; Daniel S Wilkinson; Aditya A Mohan; Sarah L Cook; John H Sampson
Journal:  Cancers (Basel)       Date:  2021-10-26       Impact factor: 6.639

2.  Atezolizumab-associated encephalitis in metastatic breast cancer: A case report.

Authors:  Guixian Chen; Changlin Zhang; Jiaying Lan; Zhenzhen Lou; Haibo Zhang; Yuanqi Zhao
Journal:  Oncol Lett       Date:  2022-07-27       Impact factor: 3.111

Review 3.  Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review.

Authors:  Burcin Özdirik; Fabian Jost-Brinkmann; Lynn Jeanette Savic; Raphael Mohr; Frank Tacke; Christoph J Ploner; Christoph Roderburg; Tobias Müller
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

4.  Case Report: Durvalumab-Associated Encephalitis in Extensive-Stage Small Cell Lung Carcinoma.

Authors:  Yosuke Shionoya; Akito Hattori; Taro Hanada; Michihiro Fujino
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.